Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients

Abstract EN

Background.

Myocardial infarction (MI) is the most terrible appearance of cardiovascular disease.

The incidence of heart failure, one of the complications of MI, has increased in the past few decades.

Therefore, the identification of MI from angina patients and the determination of new diagnoses and therapies of MI are increasingly important.

The present study was aimed at identifying differentially expressed genes and miRNAs as biomarkers for the clinical and prognosis factors of MI compared with angina using microarray data analysis.

Methods.

Differentially expressed miRNAs and genes were manifested by GEO2R.

The biological function of differentially expressed genes (DEGs) was examined by GO and KEGG.

The construction of a protein-protein network was explored by STRING.

cytoHubba was utilized to screen hub genes.

Analysis of miRNA-gene pairs was executed by the miRWalk 3.0 database.

The miRNA-target pairs overlapped with hub genes were seen as key genes.

Logistic regressive analysis was performed by SPSS.

Results.

A number of 779 DEGs were recorded.

The biological function containing extracellular components, signaling pathways, and cell adhesion was enriched.

Twenty-four hub genes and three differentially expressed miRNAs were noted.

Eight key genes were demonstrated, and 6 out of these 8 key genes were significantly related to clinical and prognosis factors following MI.

Conclusions.

CALCA, CDK6, MDM2, NRXN1, SOCS3, VEGFA, SMAD4, NCAM1, and hsa-miR-127-5p were thought to be potential diagnosis biomarkers for MI.

Meanwhile, CALCA, CDK6, NRXN1, SMAD4, SOCS3, and NCAM1 were further identified to be potential diagnosis and therapy targets for MI.